NIH Logo
 
Top navigational section of RCAS Meetings pageHome - The RCAS SystemOverviewMeetingsLiteratureRequestsRelated LinksFrequently Asked QuestionsContact Us


Plasmid Encoding an RCAS VectorTransfection of DF-1 or CEFRCAS Vector StockTesting the Behavior of Genes in Cell CultureViral Replication and BehaviorDevelopmental Studies in ChickensDream Viruses and Potential ApplicationsMouse SystemBottom of side bar menu

Fifth Workshop on TVA

April 24, 2004
Bethesda, Maryland


The Fifth Workshop on TVA was held on April 24, 2004, at the Residence Inn in Bethesda, Maryland.

Program     
 
Silvio Gutkind
National Institute of Dental and
Craniofacial Research
Welcome
 
Stephen Hughes
HIV Drug Resistance Program, NCI
The RCAS vector system
 
Sandra Orsulic
Massachusetts General Hospital
Mouse models for the molecular characterization of ovarian cancer
 
Silvia Montaner
National Institute of Dental and
Craniofacial Research
Reproducing viral diseases of the vascular endothelium
 
Sheri Holmen
Van Andel Research Institute
Modeling human melanoma in the mouse using the TVA system
 
Xiaoyi Hu
Memorial Sloan-Kettering Cancer Center
mTOR promotes survival and astrocytic characteristics induced by PTEN loss/Akt signaling in glioblastoma
 
Akrit Sodhi
National Institute of Dental and
Craniofacial Research
Examining the role of Ras in vascular tumorigenesis
 
Karen Joyce Dunn
National Human Genome Research
Institute
Wnt1 and Wnt3a affect neural crest development by distinct modes of action
 
Ling Hou
National Human Genome Research
Institute
Dissecting the hierarchical functional relationship of transcription factors in neural crest development using an RCAS-TVA-based strategy
 
Brian Lewis
University of Massachusetts
Medical School
An ALV-A pseudotyped lentivirus for the infection of non-dividing TVA+ cells
 
Jenn White
Van Andel Research Institute
Development and utility of an RCAS/TVA-based RNAi delivery system
Open Discussion
Silvio Gutkind
National Institute of Dental and
Craniofacial Research
Concluding remarks


Fourth Workshop on TVA

April 21, 2001
Boston, Massachusetts


The Fourth Workshop on TVA was held on April 21, 2001, at Tufts University School of Medicine in Boston, Massachusetts.

Program     
 
John Coffin
HIV Drug Resistance Program, NCI,
and Tufts University School of Medicine
Introduction and Welcome
 
Stephen Hughes
HIV Drug Resistance Program, NCI
Recent developments in the RCAS vector system
 
Stacie Loftus
NIH
Gateway RCAS for rapid analysis of microarray identified genes
 
Sandra Orsulic
Memorial Sloan-Kettering Cancer Center
A mouse TVA model system for ovarian cancer that allows induction of tumors through defined multiple genetic changes
 
Yi Li
Memorial Sloan-Kettering Cancer Center
Modeling cancer progression using the TVA system
 
Jay Rothstein
Thomas Jefferson University
Establishing conditional expression of RET/PTC in murine thyroids: A model for autoimmunity
 
Joyce Dunn
NCI
In utero complementation of a neural crest-derived melanocyte defect using cell directed gene transfer
 
Eric Holland
Memorial Sloan-Kettering Cancer Center
Cell differentiation and glioma formation
 
Martha Grossel
Connecticut College
Characterization of cdk4 and cdk6 functions in mouse astrocytes
 
Lijun Rong
University of Illinois at Chicago
Structure determination of the viral receptor domain of Tva: Implications in protein folding and function in ASLV-A entry
 
Mark Federspiel
Mayo Clinic
Identification of key residues in subgroup A avian leukosis virus envelope determining receptor binding affinity and infectivity of cells expressing chicken or quail Tva receptor
 
Jonah Rainey
Tufts University School of Medicine
ALV host range extension by multiple mechanisms
 
Christina Ochsenbauer-Jambor
University of Alabama
Subgroup-specific differences of RSV Env protein trafficking
 
Vineet KewalRamani
HIV Drug Resistance Program, NCI
Mechanism of virus transmission by DC-SIGN